Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Aurrigo flags revenue ahead of rebased expectations

(Sharecast News) - Aurrigo International said on Monday that it expected to report revenue of about £8m for the year ended 31 December, ahead of rebased expectations, as performance across both divisions improved despite a volatile macroeconomic backdrop. The AIM-traded transport technology group said the full-year revenue outcome compared with £8.9m in 2024 and was above market expectations that were reset in August.

Adjusted EBITDA losses and losses before tax were expected to be in line with expectations, with improving gross margins partly offset by modestly higher operating costs as the business invested in scaling its operations.

In the automotive division, the company reported a strong recovery in the second half of the year after volumes stabilised following tariff-related disruption affecting UK OEM customers in the second quarter.

As a result, second-half revenues were around 30% higher than in the first half, with full-year automotive revenue expected to be £5.4m, down from £5.9m in 2024.

The autonomous division contributed £2.5m of revenue, compared with £2.9m a year earlier, reflecting continued progress across core programmes, although some delivery milestones moved into the new financial year.

During the period, Aurrigo launched Auto-Cargo, its largest autonomous aviation vehicle to date, and signed a strategic partnership with Swissport International.

The company also reported further progress integrating autonomous solutions into airport systems and securing new projects, supported by sustained engagement with airports and ground handlers.

Aurrigo said it ended the year with cash of £11.5m, ahead of expectations, following a £13.8m net fundraising during the year.

The raise brought in new institutional shareholders as well as the company's first strategic investor, Nex Gen Mobility, leaving the group positioned to support growth initiatives.

"I am really proud of the performance of the company, with a full year outturn ahead of expectations as reset in August, which reflects how closely we work with customers to support them through uncertain market conditions," said chief executive David Keene.

"With a strong cash position and a clear pipeline of opportunities, we head into 2026 confident in the progress the company will make."

At 1211 GMT, shares in Aurrigo International were up 2.86% at 90p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

Hunting reports higher margins, full-year earnings
(Sharecast News) - Hunting reported higher earnings and margins for 2025 on Thursday despite a modest decline in revenue, as the precision engineering group benefited from improved operational performance and continued to expand shareholder returns under its long-term growth strategy.
Ibstock earnings dip as expected in 'progressively tougher market'
(Sharecast News) - Building products manufacturer Ibstock reported a drop in full-year earnings on Thursday, in line with revised guidance, in a "progressively tougher market".
OSB hikes dividend, launches buyback after fall in profit
(Sharecast News) - OSB Group reported a decline in annual profit for 2025 on Thursday as higher administrative costs and an impairment charge weighed on earnings, though the specialist lender said loan growth and originations increased and it announced a £100m share buyback alongside a higher dividend.
Spire Healthcare grows annual profits, but NHS outlook uncertain in 2026
(Sharecast News) - Takeover target and Spire Healthcare reported a small rise in adjusted profits over 2025 which it hailed as a "resilient performance" against a backdrop of significant cost headwinds, though the outlook for 2026 was proving more uncertain due to a drop in NHS commissioning activity.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.